Catatonia associated with lorazepam withdrawal.
Glover
S G
SG
Department of Psychiatry, Atlanta VA Medical Center, Decatur, GA 30033, USA.
Escalona
R
R
Bishop
J
J
Saldivia
A
A
D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002389:Catatonia / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D008140:Lorazepam / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*
D014151:Anti-Anxiety Agents; D008140:Lorazepam